The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
It’s really weird logic to think that spud news would harm the SP. It’s already dropped nearly 50% from highs and if it happens before the license is granted then so what? There’s still two massive company changing events possible in June for the price of one! Interest will resume very soon! GLA
There seems to be a lot of disgruntled long termers in this share! If you really are as pessimistic then why don’t you just sell up? I’m here for the massive drill which is now only weeks away- Herron will come when it comes!
I don’t have any experience of court hearings regarding administration but why would the court decline a relist?
*near
If the court date has been delayed (and due to take place in smear future then I’m sure Armistice would happily extend the deadline. Would be crazy for them to pull out at this late stage due to matters outside 4D’s control! I would expect an RNS on Monday clarifying the situation though!!
It’s way too early to have any idea what the price will be. If the relist comes with some great data on MRX0518, positive updates on the vaccine collab with Merk then people will be all over this share. It’s all about progress now- let’s hope some has been made over the past 7 months
Who in their right mind would vote against it? Surely 100% of votes cast will be in favour?
You have to remember that any vote not cast will be assumed to be an acceptance of the proposals! There’s no way this won’t be voted through- it?s just procedure!
If I remember rightly, the loan amount doesn’t necessarily have to be turned into shares. I think 4D do have the option to pay off the loan amount though other means. This could be for instance a licensing deal or milestone payments from Merck. This would reduce the dilution considerably!
As per an email from 4D’s IR
‘Inline with the submission regulations provided by ESMO, there will be new information. As with our prior presentations at similar events, investors should expect an RNS around the time of the conference.
Hi, I’m a teacher and was just told by by head that we will soon be getting faster COVID tests that give quicker results (and only have to swab the lower part of a nostril). I don’t hold shares on AVCT but followed the story and sounds familiar. Do we know which company will be making these tests? Could it be AVCT?
Where are you getting October from? We are due readouts in June and September for Mrx 0518 and asthma and pancreatic cancer readouts in between (July/ August)
Although they’re not delayed at all- they are due before May 31st. Later than the rough estimate given in the last RNS but NOT delayed
I think people were hoping that listing on the NASDAQ would raise 4D’s market cap closer to their microbiome peers over there! I expect this to happen in the coming weeks as the Americans get to grips with the company and its world leader credentials